Snowball logo
logo
Оценка
Бета
28,21
Другое
Размер лота
1 шт.
О компании
Тикер
ERGO
ISIN
US29481Q1094
Страна
США
Сектор (GICS)
Здравоохранение
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Часто задаваемые вопросы

В каком секторе работает Entia Biosciences Inc (ERGO)?

Entia Biosciences Inc относится к сектору Здравоохранение.

Какова текущая цена акций Entia Biosciences Inc (ERGO)?

По последним данным, цена акций Entia Biosciences Inc составляет 0,00 $, предыдущее закрытие — 0,00 $.

Выплачивает ли Entia Biosciences Inc (ERGO) дивиденды?

Нет, Entia Biosciences Inc не выплачивает дивиденды.

Какой бета-коэффициент (волатильность) у Entia Biosciences Inc (ERGO)?

У компании Entia Biosciences Inc бета 28.210, что свидетельствует о крайне высокой волатильности по сравнению с рынком